MA
Mandelman
Member since 2025
Views
13k Total number of views
Fair Values Set
158 Total number of fair values set
Comments
1 Total number of comments
Followers
3 Total number of followers
No bio added yet
No link added
I-Tech
27.3% undervalued intrinsic discount
I-Tech's Selektope Expansion Will Drive 28% Revenue Increase in 5 Years
View narrativeMA
Updated 19 Oct 2025
Qt Group Oyj
7.5% undervalued intrinsic discount
Qt Group Oyj’s somewhat overvalued, but with a potential for extra dividends
View narrativeMA
Published 13 Sep 2025
Sleep Cycle
43.6% undervalued intrinsic discount
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
View narrativeMA
Updated 23 Aug 2025
Cadeler
39.1% undervalued intrinsic discount
Cadeler set to grow with market.
View narrativeMA
Updated 31 Aug 2025
Mycronic
30.0% overvalued intrinsic discount
Historically Cheap, but the Margin of Safety Is Still Thin
View narrativeMA
Published 18 Jun 2025
Invisio
56.6% undervalued intrinsic discount
Invisio Will Ride Strong Market Tailwinds to Achieve 29% Revenue Growth
View narrativeMA
Updated 23 Feb 2025
HEXPOL
21.6% undervalued intrinsic discount
HEXPOL AB: Sustained Long Term Growth, Stable Margins, and Strategic M&A
View narrativeMA
Published 22 Mar 2025
EQL Pharma
70.7% undervalued intrinsic discount
EQL Pharma's management aiming for 30% Revenue Growth in 5 Years
View narrativeMA
Updated 16 Aug 2025
Nederman Holding
11.4% undervalued intrinsic discount
Nederman: Cautiously Overvalued Amid Modest Growth and Margin uncertainties
View narrativeMA
Updated 24 Mar 2025